CMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
Cantel Medical's Net-Net Working Capital for the quarter that ended in Apr. 2021 was $-18.51.
The industry rank for Cantel Medical's Net-Net Working Capital or its related term are showing as below:
The historical data trend for Cantel Medical's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cantel Medical Annual Data | |||||||||||||||||||||
Trend | Jul11 | Jul12 | Jul13 | Jul14 | Jul15 | Jul16 | Jul17 | Jul18 | Jul19 | Jul20 | |||||||||||
Net-Net Working Capital | Get a 7-Day Free Trial | -2.30 | -2.24 | -2.83 | -4.43 | -20.61 |
Cantel Medical Quarterly Data | ||||||||||||||||||||
Jul16 | Oct16 | Jan17 | Apr17 | Jul17 | Oct17 | Jan18 | Apr18 | Jul18 | Oct18 | Jan19 | Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | |
Net-Net Working Capital | Get a 7-Day Free Trial | -21.47 | -20.61 | -19.48 | -19.28 | -18.51 |
For the Medical Instruments & Supplies subindustry, Cantel Medical's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where Cantel Medical's Price-to-Net-Net-Working-Capital falls into.
Cantel Medical's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Jul. 2020 is calculated as
Net-Net Working Capital | (A: Jul. 2020 ) | ||||||
= | (Cash, Cash Equivalents, Marketable Securities | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (277.871 | + | 0.75 * 148.419 | + | 0.5 * 167.96 | - | 1342.155 |
- | 0 | - | 0) | / | 42.1622 | ||
= | -20.61 |
Cantel Medical's Net-Net Working Capital (NNWC) per share for the quarter that ended in Apr. 2021 is calculated as
Net-Net Working Capital | (Q: Apr. 2021 ) | ||||||
= | (Cash, Cash Equivalents, Marketable Securities | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (218.528 | + | 0.75 * 164.929 | + | 0.5 * 179.078 | - | 1214.088 |
- | 0 | - | 0) | / | 42.2735 | ||
= | -18.51 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
Cantel Medical (NYSE:CMD) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
Thank you for viewing the detailed overview of Cantel Medical's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.
Ann E Berman | director | 255 STATE STREET, BOSTON MA 02109 |
Jeffrey Z Mann | officer: SVP, General Counsel | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
George L Fotiades | director, officer: Chief Executive Officer | 281 SUMMIT AVENUE, SUMMIT NJ 07901 |
Charles M Diker | director, 10 percent owner, officer: Chairman | ONE NEW YORK PLAZA, NEW YORK NY 10004 |
Shaun M. Blakeman | officer: SVP - CFO | C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Jean Casner | officer: SVP and CHRO | 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Brian Capone | officer: SVP and Princ. Accounting Ofr | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Peter G Clifford | officer: President and COO | 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047 |
Seth M Yellin | officer: Executive Vice President | 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424 |
Laura L Forese | director | 849 STONEWALL COURT FRANKLIN LAKES NJ 07417 |
Peter Pronovost | director | JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231 |
Anthony B Evnin | director | C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018 |
Ronnie Myers | director | TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595 |
Alan R Batkin | director | 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022 |
Karen Prange | director | 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316 |
From GuruFocus
By PRNewswire PRNewswire • 02-09-2021
By Marketwired Marketwired • 01-12-2021
By PRNewswire PRNewswire • 10-01-2020
By PRNewswire PRNewswire • 01-13-2021
By Marketwired Marketwired • 01-14-2021
By Marketwired Marketwired • 01-14-2021
By GuruFocus Research GuruFocus Editor • 01-29-2021
By PRNewswire PRNewswire • 05-21-2020
By PRNewswire PRNewswire • 04-01-2020
By PRNewswire PRNewswire • 12-07-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.